Related content

d-Chiro-inositol and its significance in polycystic ovary syndrome: a systematic review

By Galazis Nicolas   Galazi Myria   Atiomo William  

Gynecological Endocrinology, Vol. 27, Iss. 4, 2011-04 ,pp. : 256-262

Informa Healthcare

Access to resources Recommend Favorite

Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients

By Genazzani Alessandro D.   Prati Alessia   Santagni Susanna   Ricchieri Federica   Chierchia Elisa   Rattighieri Erica   Campedelli Annalisa   Simoncini Tommaso   Artini Paolo G.  

Gynecological Endocrinology, Vol. 28, Iss. 12, 2012-12 ,pp. : 969-973

Informa Healthcare

Access to resources Recommend Favorite

D- chiro -inositol is more effective than myo -inositol in preventing folate-resistant mouse neural tube defects

By Cogram Patricia  

Human Reproduction, Vol. 17, Iss. 9, 2002-09 ,pp. : 2451-2458

Oxford University Press

Access to resources Recommend Favorite

Growth hormone secretion is impaired but not related to insulin sensitivity in non‐obese patients with polycystic ovary syndrome

By de Boer Jacoba A.M.  

Human Reproduction, Vol. 19, Iss. 3, 2004-03 ,pp. : 504-509

Oxford University Press

Access to resources Recommend Favorite

The relationship of urotensin II with insulin resistance and hs-CRP in patients having PCOS

By Yilmaz Özgür   Calan Ozlem   Kume Tuncay   Calan Mehmet  

Gynecological Endocrinology, Vol. 29, Iss. 11, 2013-11 ,pp. : 970-973

Informa Healthcare

Access to resources Recommend Favorite